January 16, 2019 – Eurostars Grant awarded to Scenic

Scenic Biotech BV, a pioneer in the discovery of genetic modifiers to enable the development of disease modifying therapeutics for rare genetic disorders and other devastating illnesses, has been awarded a prestigious Eurostars grant for one of its R&D programs in the Immune Oncology space.